Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0390
-0.0030 (-7.14%)
Oct 1, 2026, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 19.1 million as of October 1, 2026. Its market cap has decreased by -78.83% in one year.
Market Cap
19.10M
Enterprise Value
22.77M
Revenue
2.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 19.10M, an increase of 158.84%. That is a compound annual growth rate of 4.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 19.10M | -83.50% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 28.03M |
| NeuroScientific Biopharmaceuticals | 24.16M |
| Neurotech International | 22.62M |
| Proteomics International Laboratories | 20.67M |
| Patrys | 20.25M |
| Noxopharm | 18.43M |
| Algorae Pharmaceuticals | 18.25M |
| Argenica Therapeutics | 17.98M |